Checkpoint Therapeutics, Inc. Profile Avatar - Palmy Investing

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candi…

Biotechnology
US, Waltham [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Checkpoint Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Checkpoint Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Checkpoint Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of CKPT's Analysis
CIK: 1651407 CUSIP: 162828107 ISIN: US1628282063 LEI: - UEI: -
Secondary Listings
CKPT has no secondary listings inside our databases.